Modulation of Breast Cancer Risk Biomarkers by High Dose Vitamin D

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
Breast Cancer
Interventions
DRUG

vitamin D3

oral capsules, 10,000 IU per week for 6 months

Trial Locations (1)

66160

University of Kansas Medical Center, Kansas City

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

BTR Group

INDUSTRY

lead

Carol Fabian, MD

OTHER